Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA
by Jon Henley and Sarah Boseley from Science | The Guardian on (#5FBXY)
European regulator seeks to allay blood fears as Germany, France and Italy suspend use
Europe's medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot's benefits outweigh the risks after four major EU countries announced they were suspending its use.
Germany, France, Italy and Spain temporarily halted inoculations with the vaccine on Monday after reported incidents of bleeding, blood clots and a low count of blood platelets in some people who had received it.
Continue reading...